Maria-Magdalena Patru, MD, PhD, is an experienced physician-scientist, with over 15 years in the field and more than 11 years in the in vitro diagnostics industry. Currently serving as the scientific partner for neurology at Roche Diagnostics US, she leads a team developing medical strategies for neurology biomarkers, primarily focusing on Alzheimer’s disease. Her background includes a medical degree, laboratory medicine training, a PhD in microbiology and immunology, a clinical laboratory fellowship, and extensive experience in medical and scientific affairs, particularly in IVD product development, validation, and clinical trials.
Articles by Maria-Magdalena Patru, MD, PhD
Updated |3 min read
Blood-Based Biomarkers Are Transforming the Diagnosis of Alzheimer’s Disease
Real-world validation continues to reinforce the utility of blood-based biomarkers in Alzheimer’s disease for earlier and more accurate diagnosisPage 1 of 1
